title: Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention.
authors.affiliation: Duke Clinical Research Institute, Durham, North Carolina 27715, USA. roe00001@mc.duke.edu
authors.forename: M T
authors.initials: MT
authors.lastname: Roe
authors.forename: C B
authors.initials: CB
authors.lastname: Granger
authors.forename: J A
authors.initials: JA
authors.lastname: Puma
authors.forename: A S
authors.initials: AS
authors.lastname: Hellkamp
authors.forename: J S
authors.initials: JS
authors.lastname: Hochman
authors.forename: E M
authors.initials: EM
authors.lastname: Ohman
authors.forename: H D
authors.initials: HD
authors.lastname: White
authors.forename: F
authors.initials: F
authors.lastname: Van de Werf
authors.forename: P W
authors.initials: PW
authors.lastname: Armstrong
authors.forename: S G
authors.initials: SG
authors.lastname: Ellis
authors.forename: R M
authors.initials: RM
authors.lastname: Califf
authors.forename: E J
authors.initials: EJ
authors.lastname: Topol
mesh_terms: D000368:Aged; D000789:Angina, Unstable / Q000188:drug therapy* / Q000628:therapy; D015906:Angioplasty, Balloon, Coronary; D006328:Cardiac Catheterization; D005260:Female; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use*; D024764:Hirudin Therapy; D006629:Hirudins / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000188:drug therapy* / Q000628:therapy; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use*; D055502:Secondary Prevention; D013577:Syndrome
chemical_list: D006629:Hirudins; D011994:Recombinant Proteins; D006493:Heparin; C060225:desirudin